Skip to main content
. 2013 Jun 19;17(3):447–454. doi: 10.1093/icvts/ivt265

Table 2:

Univariate analysis for factors associated with Station 3A lymph node metastasis

Variables OR 95% CI P-value
Gender
 Male 0.705 0.318, 1.566 0.391
 Female
Age (years)
 <50 1.927 0.589, 6.289 0.278
 50–70 2.745 0.976, 7.720 0.156
 >70*
Tumour location
 RUL 0.475 0.056, 4.023 0.495
 RML 0.531 0.051, 5.553 0.579
 RLL 0.839 0.091, 7.769 0.877
 RH*
Histopathology
 Sq 0.175 0.064, 0.480 0.001
 Non-Sq
Tumour size (cm)
 <2 1.829 0.293, 11.427 0.519
 2–3 1.782 0.305, 10.413 0.521
 3–5 2.089 0.349, 12.489 0.419
 >5*
Skipping metastasis
 Skipping 0.585 0.271, 1.261 0.171
 Non-skipping
Metastasis of #2 LNs
 Positive 2.598 1.193, 5.654 0.016
 Negative
Metastasis of #4 LNs
 Positive 4.716 1.722, 12.916 0.003
 Negative
Metastasis of #7 LNs
 Positive 0.660 0.274, 1.315 0.202
 Negative
Metastasis of #8 LNs
 Positive 0.917 0.249, 3.376 0.897
 Negative
Metastasis of #9 LNs
 Positive 0.481 0.106, 2.188 0.344
 Negative

RUL: right upper lobe; RML: right middle lobe; RLL: right lower lobe; RH: right hilum; Sq: squamous cell carcinoma; non-Sq: non-squamous cell carcinoma; OR: odds ratios; CI: confidence intervals; LN: lymph node; #: the station number of mediastinal lymph nodes;

*Reference category.